N

NexgenRx Inc
XTSX:NXG

Watchlist Manager
NexgenRx Inc
XTSX:NXG
Watchlist
Price: 0.38 CAD Market Closed
Market Cap: 27m CAD

Intrinsic Value

NXG doesn't have a meaningful market cap.

The intrinsic value of one NXG stock under the Base Case scenario is 0.41 CAD. Compared to the current market price of 0.38 CAD, NexgenRx Inc is Undervalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NXG Intrinsic Value
0.41 CAD
Undervaluation 6%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
NexgenRx Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about NXG?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NXG valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for NexgenRx Inc.

Explain Valuation
Compare NXG to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NXG?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
NexgenRx Inc

Current Assets 33.8m
Cash & Short-Term Investments 2.5m
Receivables 965.9k
Other Current Assets 30.3m
Non-Current Assets 5.4m
Long-Term Investments 296k
PP&E 883.2k
Intangibles 2.9m
Other Non-Current Assets 1.3m
Current Liabilities 30.5m
Accounts Payable 481.4k
Other Current Liabilities 30m
Non-Current Liabilities 392.7k
Long-Term Debt 392.7k
Efficiency

Free Cash Flow Analysis
NexgenRx Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
NexgenRx Inc

Revenue
17.5m CAD
Cost of Revenue
-3m CAD
Gross Profit
14.4m CAD
Operating Expenses
-12.6m CAD
Operating Income
1.8m CAD
Other Expenses
-498.2k CAD
Net Income
1.3m CAD
Fundamental Scores

NXG Profitability Score
Profitability Due Diligence

NexgenRx Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
ROE is Increasing
Strong 3Y Average Gross Margin
ROIC is Increasing
51/100
Profitability
Score

NexgenRx Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

NXG Solvency Score
Solvency Due Diligence

NexgenRx Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
58/100
Solvency
Score

NexgenRx Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NXG Price Targets Summary
NexgenRx Inc

There are no price targets for NXG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NXG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one NXG stock?

The intrinsic value of one NXG stock under the Base Case scenario is 0.41 CAD.

Is NXG stock undervalued or overvalued?

Compared to the current market price of 0.38 CAD, NexgenRx Inc is Undervalued by 6%.

Back to Top